U.S. SECURITIES AND EXCHANGE COMMISSION

Securities Exchange Act of 1934
Release No. 37832 / October 18, 1996

                      
In the Matter of Andrew Bressman, Roman Okin, Richard Acosta,
Richard Simone, Burton Blank, Mark Goldman, and Jack Wolynez 
(Administrative Proceeding File No. 3-9168)

     The Commission today instituted public administrative
proceedings as to Andrew Bressman, Roman Okin, Richard Acosta,
Richard Simone and Mark Goldman alleging that they committed
fraud in violation of the securities laws and as to Goldman,
Burton Blank and Jack Wolynez alleging that they failed
reasonably to supervise persons subject to their supervision.  

     The Commission alleges that in 1991, Bressman, Acosta and
others, as registered representatives of D.H. Blair & Co., Inc.
("Blair"), manipulated the market for the common stock of
Professional Care, Inc., and in 1992, Bressman, Okin, Acosta and
others, manipulated the market for the common stock of Health
Professionals, Inc. ("HPI"), PCI's successor.  In 1993, Bressman,
Okin, Acosta and others, through A.R. Baron & Co., Inc.
("Baron"), again manipulated the market for HPI common stock. 
The Commission also alleges that in 1995, Bressman and Okin,
through Baron, manipulated the market for the common stock of
Cypros Pharmaceutical Corp.  Over an extended period of time
during their tenure at Blair and Baron, Bressman, Okin and Acosta
allegedly engaged in repeated and egregious sales practice
abuses, including unauthorized trading in customer accounts. 
Simone, during his tenure at Baron, placed large unauthorized
trades in a customer's account and Goldman, on several occasions,
refused to carry out customer sell orders.  The Commission
alleges that by virtue of this conduct Bressman, Okin and Acosta
willfully violated Section 17(a) of the Securities Act of 1933
("Securities Act") and Sections 9(a)(2), 9(a)(4) and 10(b) of the
Securities Exchange Act of 1934 ("Exchange Act") and Rule 10b-5
thereunder, and willfully aided and abetted and caused violations
of Sections 7(c) and 15(c)(1) of the Exchange Act and Rule 15c1-2
thereunder and Regulation T promulgated by the Federal Reserve
Board; Simone willfully violated Section 17(a) of the Securities
Act and Section 10(b) of the Exchange Act and Rule 10b-5
thereunder; and Goldman willfully violated Sections 9(a)(2) and
10(b) of the Exchange Act and Rule 10b-5 thereunder, and
willfully aided and abetted and caused violations of Section
15(c)(1) of the Exchange Act and Rule 15c1-2 thereunder.  The
Commission alleges that Blank, Goldman and Wolynez failed
reasonably to supervise persons subject to their supervision and
to detect and prevent the manipulative conduct and repeated and
numerous sales abuses. 

     The administrative proceeding will determine whether
==========================================START OF PAGE 2======

remedial action is appropriate under:  Section 8A of the
Securities Act and Sections 15(b)(6), 19(h), 21B and 21C of the
Exchange Act as to Bressman, Okin, Acosta, Simone and Goldman;
and Sections 15(b)(6), 19(h) and 21B of the Exchange Act as to
Blank and Wolynez.